Line 99: | Line 99: | ||
<div class="sub-title">Team Collaboration</div> | <div class="sub-title">Team Collaboration</div> | ||
<div class="article-title" style="line-height: 40px;">Collaboration with Team Pansolver Base (Official Team | <div class="article-title" style="line-height: 40px;">Collaboration with Team Pansolver Base (Official Team | ||
− | Name: | + | Name: Shanghai_HS_ID)</div> |
<div class="img-wrap no-margin"> | <div class="img-wrap no-margin"> | ||
<img src="https://static.igem.org/mediawiki/2021/d/d3/T--Shanghai_HS_ID--collaboration01.png" alt="" /> | <img src="https://static.igem.org/mediawiki/2021/d/d3/T--Shanghai_HS_ID--collaboration01.png" alt="" /> | ||
Line 108: | Line 108: | ||
<div class="article-content">We vigorously collaborated with another iGEM team called Pansolver Base(Official | <div class="article-content">We vigorously collaborated with another iGEM team called Pansolver Base(Official | ||
Team | Team | ||
− | Name: | + | Name: Shanghai_HS_ID). Their project mainly focused on improving the stability of maritime transportation of |
medicines and antibodies, as well as testing for possible deactivation of antibodies towards several mutants | medicines and antibodies, as well as testing for possible deactivation of antibodies towards several mutants | ||
of SARS-CoV-2 (B.1.1.7, B.1.351, B.1.617, etc.). We shared ideas about methods to publicize our projects and | of SARS-CoV-2 (B.1.1.7, B.1.351, B.1.617, etc.). We shared ideas about methods to publicize our projects and | ||
Line 123: | Line 123: | ||
reports, peer-edited them, and gave insights about how to dig deeper significance of each other’s projects. | reports, peer-edited them, and gave insights about how to dig deeper significance of each other’s projects. | ||
</div> | </div> | ||
− | <div class="article-title" style="line-height: 40px;">Collaboration with | + | <div class="article-title" style="line-height: 40px;">Collaboration with Pec Teast (Official Team Name: 2021 |
− | + | iGEM team Xiamen_City) | |
</div> | </div> | ||
<div class="img-wrap no-margin"> | <div class="img-wrap no-margin"> | ||
− | <img src="https://static.igem.org/mediawiki/2021/ | + | <img style="display: inline-block; width: 49%;" |
+ | src="https://static.igem.org/mediawiki/2021/f/fc/T--Shanghai_HS_ID--chg127.png" alt="" /> | ||
+ | <img style="display: inline-block; width: 49%;" | ||
+ | src="https://static.igem.org/mediawiki/2021/4/46/T--Shanghai_HS_ID--chg1271.png" alt="" /> | ||
+ | <span>Picture one: Our online discussion with Pec Teast</span> | ||
</div> | </div> | ||
<div class="article-content"> | <div class="article-content"> | ||
− | + | Pec Teast strives to use CRISPR-Cas 9 technology to obtain a modified strain of yeast able to simultaneously | |
− | + | digest pectin and ferment alcohol, creating convenient and economic manufacturing methods of these | |
− | we | + | materials. Since we started our training one month before team Pec Teast, we provided them with guidance of |
− | + | the general competition layout and the work distribution of the wet team and dry team. During our online | |
− | + | discussions, we focused on the basic experimental procedures for CRISPR-Cas9, including the construction of | |
− | + | the right and left homologous arms, the synthesis of the CRISPR-Cas 9 protein complex, and final | |
− | + | verifications. We also exchanged dry team schedules, including checklists and dates for wiki materials, | |
− | + | formatting, and inspirations for merch product designs. In the marketing respect, we inspired them to refine | |
− | + | their target audience to only a specific sector of the general public, just like how our team only targets | |
+ | professional manufacturing and medicine companies. | ||
</div> | </div> | ||
</div> | </div> |
Latest revision as of 14:09, 7 December 2021
Team Collaboration
Collaboration with Team Pansolver Base (Official Team
Name: Shanghai_HS_ID)
We vigorously collaborated with another iGEM team called Pansolver Base(Official
Team
Name: Shanghai_HS_ID). Their project mainly focused on improving the stability of maritime transportation of
medicines and antibodies, as well as testing for possible deactivation of antibodies towards several mutants
of SARS-CoV-2 (B.1.1.7, B.1.351, B.1.617, etc.). We shared ideas about methods to publicize our projects and
possible sponsors for our labs. Most memorably, we learned from their creativity. As a tactic to promote
their project, they constructed a game of Murder Mystery, in which players perform as specific characters
according to a script, and through logical reasoning, find the “killer”. In the script, they inform players
about their use of technology, and the importance of pandemic prevention and control. The script is written
based on the project that Panslover is doing, hence there's a character named "Pansolver", who is the key to
the game. Such informative games are great tools to elicit people's engagement, our team planned to create
similar games during our further team promotion in the future. We intensely communicated our interviews at
Bright Dairy & Food Co., Ltd, and with the professors of Fudan University. Both teams also actively engaged
in discussions about innovations of merchandise – agreeing about making T-shirts, and chatted about setting
up a stall. At the dusk of the day, we exchanged drafts of our integrated human practice documents and lab
reports, peer-edited them, and gave insights about how to dig deeper significance of each other’s projects.
Collaboration with Pec Teast (Official Team Name: 2021
iGEM team Xiamen_City)
Picture one: Our online discussion with Pec Teast
Pec Teast strives to use CRISPR-Cas 9 technology to obtain a modified strain of yeast able to simultaneously
digest pectin and ferment alcohol, creating convenient and economic manufacturing methods of these
materials. Since we started our training one month before team Pec Teast, we provided them with guidance of
the general competition layout and the work distribution of the wet team and dry team. During our online
discussions, we focused on the basic experimental procedures for CRISPR-Cas9, including the construction of
the right and left homologous arms, the synthesis of the CRISPR-Cas 9 protein complex, and final
verifications. We also exchanged dry team schedules, including checklists and dates for wiki materials,
formatting, and inspirations for merch product designs. In the marketing respect, we inspired them to refine
their target audience to only a specific sector of the general public, just like how our team only targets
professional manufacturing and medicine companies.